Northwestern Medicine

Running trials

• Not yet recruiting

  Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)

  NCT07216859· Kaiser Permanente· Source

• Recruiting

  A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)

  NCT07919678· Phase 3· Pfizer· Source

• Recruiting

  A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

  NCT07464925· Phase 1· Tetragon Biosciences Ltd· Source

• Recruiting

  Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

  NCT07473778· Gilead Sciences· Source

• Recruiting

  The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms

  NCT07143019· phenox Inc.· Source

• Recruiting

  Increasing Germline Genetic Testing for Patients With Cancer

  NCT07307664· Josh Peterson· Source

• Recruiting

  A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

  NCT06994676· Phase 1· Crossbow Therapeutics, Inc.· Source

• Not yet recruiting

  Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY)

  NCT06973629· Phase 3· Brainstorm-Cell Therapeutics· Source

• Recruiting

  A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

  NCT06991257· Phase 2· Pfizer· Source

• Recruiting

  Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

  NCT06560762· Phase 1· Secretome Therapeutics· Source

• Active, not recruiting

  A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

  NCT06255028· Phase 1· Century Therapeutics, Inc.· Source

• Active, not recruiting

  The Study in Outpatient Medicine Using Nudges to Improve Sleep

  NCT06640023· University of Southern California· Source

• Active, not recruiting

  Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation

  NCT06501625· Phase 1/2· Institut de Recherches Internationales Servier· Source

• Enrolling by invitation

  AI Echocardiographic Screening of Cardiac Amyloidosis

  NCT06664866· Cedars-Sinai Medical Center· Source

• Recruiting

  Mechanical Alignment vs Kalipered Kinematic Alignment Total Knee Arthroplasty

  NCT06617871· Northwestern University· Source

• Recruiting

  Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05571059· Phase 2· Cumberland Pharmaceuticals· Source

• Recruiting

  A Registry for People With T-cell Lymphoma

  NCT05978141· Memorial Sloan Kettering Cancer Center· Source

• Active, not recruiting

  A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

  NCT05794906· Phase 3· Bayer· Source

• Recruiting

  Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

  NCT05633654· Phase 3· Gilead Sciences· Source

• Recruiting

  A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

  NCT05548296· Phase 2· Acrivon Therapeutics· Source

• Active, not recruiting

  Study to Learn If Tofersen (BIIB067) Can Delay ALS Symptoms and About Its Safety in Adults With a SOD1 Gene Mutation Who Have Not Yet Developed ALS Symptoms

  NCT04856982· Phase 3· Biogen· Source

• Enrolling by invitation

  ROSE for Improved Molecular Marker Testing Via EBUS

  NCT04945317· Johns Hopkins University· Source

• Active, not recruiting

  Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil

  NCT03992755· Phase 3· Liquidia Technologies, Inc.· Source

• Active, not recruiting

  International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry

  NCT04496687· SCAD Alliance· Source

• Active, not recruiting

  AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment

  NCT03732794· AtriCure, Inc.· Source

• Recruiting

  Cardiogenic Shock Working Group Registry

  NCT04682483· Tufts Medical Center· Source

• Active, not recruiting

  Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

  NCT03012321· Phase 2· Northwestern University· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure5 recruiting
• Childhood cancers3 recruiting
• Osteoarthritis2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Acute myeloid leukaemia1 recruiting
• ALS (motor neurone disease)1 recruiting
• Amyloidosis1 recruiting
• Brain aneurysm1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Colorectal cancer1 recruiting
• Coronary artery disease1 recruiting
• Endometrial cancer1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Glioblastoma1 recruiting
• HIV1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• Liver cirrhosis1 recruiting
• Lung cancer1 recruiting
• Myelodysplastic syndromes1 recruiting
• Obesity1 recruiting
• Pancreatic cancer1 recruiting
• Stroke1 recruiting
• Triple-negative breast cancer1 recruiting

Closed trials

• Completed

  Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

  NCT06234488· Medical College of Wisconsin· Source

• Completed

  A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.

  NCT05059236· Phase 2· Bayer· Source

• Completed

  A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease

  NCT05047263· Phase 3· Bayer· Source

• Completed

  LIFT Intervention in Liver Transplant Candidates

  NCT04836923· Northwestern University· Source

• Completed

  Trial of Parkinson's And Zoledronic Acid

  NCT03924414· Phase 4· California Pacific Medical Center Research Institute· Source

• Completed

  Long-Term PF-06651600 for the Treatment of Alopecia Areata

  NCT04006457· Phase 3· Pfizer· Source

• Completed

  Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?

  NCT03269994· Phase 3· Memorial Sloan Kettering Cancer Center· Source

• Terminated

  A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma

  NCT03215030· Phase 1/2· Teva Branded Pharmaceutical Products R&D LLC· Source

• Completed

  A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

  NCT02815891· Target PharmaSolutions, Inc.· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Ulcerative colitis24 works · 0 trials